Our data revealed that BAFF serves as a potential stimulator of unhealthy adipose-tissue expansion by triggering inflammation and fibrosis and ultimately leading to enhanced insulin resistance and NAFLD. The gene discussed is TNFSF13B; the disease is metabolic dysfunction-associated steatotic liver disease.